Norcantharidin Nanostructured Lipid Carrier (NCTD-NLC) Suppresses the Viability of Human Hepatocellular Carcinoma HepG2 Cells and Accelerates the Apoptosis

Malignant tumors have become the main cause of harm to human life and health. Development for new antitumor drugs and the exploration to drug carriers are becoming the concerned focus. In this study, we exploited our experiments to explore the effect of NCTD-NLC on liver cancer cells: the HepG2 cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Zijun, Yang, Kun, Tang, Xiang, Bi, Yunfeng, Ding, Yuzhen, Deng, Mengyue, Xia, Die, Zhao, Yunqi, Chen, Tong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045966/
https://www.ncbi.nlm.nih.gov/pubmed/35497873
http://dx.doi.org/10.1155/2022/3851604

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045966/
https://www.ncbi.nlm.nih.gov/pubmed/35497873
http://dx.doi.org/10.1155/2022/3851604

Ejemplares similares